Catatonia syndrome

  • Milica Milinović Vojna bolnica Novi Sad
  • Marko Todorovic MMA Belgrade
DOI: https://doi.org/10.5937/halo26-27509
Keywords: catatonia, diagnosis, differential diagnosi

Abstract


Catatonic syndrome is a occurs as part of mood disorders, catatonic schizophrenia, conversion disorders, neurological or metabolic disorders, toxic infections of the CNS, viral infections and autoimmune diseases. In the case report, the diagnosis of dissociative stupor can be made even though somatic symptoms because they potentiate other symptoms. Diagnosis was made for several reasons. Due to the existence of a temporal relationship between the onset of symptoms of the disorder and stressful events. Due to the deep reduction of voluntary movements, speech and normal reaction to light, noise and touch, with maintained normal muscle tone, body posture and breathing. The key developmental task, the patient's transition from the phase of fusion with the mother and dependence on her to a state of increased independence. Diagnosis and therapy according to the order of urgency and severity clinical picture and after prolonged inpatient treatment is indicated drug therapy and psychotherapeutic support.

 

References

1. Kecmanović D. Psihijatrija. Beograd – Zagreb: Medicinska knjiga, 1989.
2. Jašović-Gašić M, Lečić-Toševski D. (ur). Psihijatrija za studente medicinskog fakulteta. Engrami. 2008;30(2):77-79.
3. Ungvari GS, Caroll BT. Foundations for the classification of catatonias. Mov Disord. 2000; 15:180-1. PMID: 10634267. doi: 10.1002/1531-8257(200001)15:1<180::aid-mds1035>3.0.co;2-k.
4. Philbrick KL, Rummans TA. Malignant catatonia. J Neuropsychiatry Clin Neurosci. 1994; 6(1):1-13. PMID: 7908547. doi: 10.1176/jnp.6.1.1.
5. Northoff G. What catatonia can tell us 25(5):555-77; discussion 578-604. PMID: 12958742. doi: 10.1017/s0140525x02000109.:555-77.
6. Northoff G. Eckert J, Fritze J. Glutamatergic dysfunction in catatonia? Successful treatment of three akinetic catatonic patients with NMDA antagonist amantadine. J Neurol Neurosurg Psychiatry. 1997; 62(4):404-6. PMID: 9120462. doi: 10.1136/jnnp.62.4.404.
7. Verma K, Jayadeva V, Serrano R, Sivashanker K. Diagnostic, treatment, and system challenges in the management of recurrent neuroleptic malignant syndrome on a general medical service. Case Rep Psychiatry. 2018;2018:4016087. PMID: 29992074. DOI: 10.1155/2018/4016087
8. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2012.
9. Braga CM, Pina IF, Cantilino A, Machado L. Catatonia - not only a schizophrenia subtype: a case report of Wilson's disease. Br J Psychiatry. 2019; 41(5):460-462. PMID: 31644781. DOI: 10.1590/1516-4446-2019-0558.
10. Rajagopal S. Catatonia. Advances in Psychiatric Treatment. 2007; 13:51-59.
11. Sadock BJ, Sadock VA. Kaplan & Sadock’s Synopsis of Psychiatry. Philadelphia: Lippincot Williams&Wilkins; 2007.
12. Walther S, Stegmayer K, Wilson JE, Heckers S. Structure and neural mechanisms of catatonia. Lancet Psychiatry. 2019; 6(7):610-619. PMID: 31196794. DOI: 10.1016/S2215-0366(18)30474-7.
13. Kaličanin P. Psihijatrija. Beograd: Elit medica; 2002.
14. ICD-10. Međunarodna klasifikacija mentalnih poremećaja i poremećaja ponašawa. Beograd: Zavod za udžbenike i nastavna sredstva; 1992.
15. Ohi K, Kuwata A, Shimada T, Yasuyama T, Nitta Y, Uehara T, et al. Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report. Medicine (Baltimore). 2017;96(16):e6566. PMID: 28422845. doi: 10.1097/MD.0000000000006566.
16. Spiegel DR, Glad R, Smith M, Raja U, Wade R, Johnson K. A case of schizophrenia with catatonia resistant to lorazepam and olanzapine monotherapy but responsive to combination treatment: Is it time to consider using select second-generation antipsychotics earlier in the treatment algorithm for this patient type? Clin Neuropharmacol. 2019;42(2):57-59. PMID: 30762605. DOI: 10.1097/WNF.0000000000000327.
17. Benarous X, Raffin M, Ferrafiat V, Consoli A, Cohen D. Catatonia in children and adolescents: New perspectives. Schizophr Res. 2018;200:56-67. PMID: 28754582. DOI: 10.1016/j.schres.2017.07.028.
18. Stip E, Blain-Juste ME, Farmer O, Fournier-Gosselin MP, Lespérance P. Catatonia with schizophrenia: From ECT to rTMS. Encephale. 2018; 44(2):183-187. PMID: 29241672. DOI: 10.1016/j.encep.2017.09.008.
19. Wong JW, Williams SR. The Wandering Woman: A case study of catatonia vs factitious disorder. Hawaii J Med Public Health. 2017;76(3):82-84. PMID: 28352494.
20. Chen RA, Huang TL. Periodic catatonia with long-term treatment: a case report. BMC Psychiatry. 2017;17(1):337. PMID: 28962597. doi: 10.1186/s12888-017-1497-6.
21. Ungvari GS, Gerevich J, Takács R, Gazdag G. Schizophrenia with prominent catatonic features: A selective review. Schizophr Res. 2018;200:77-84. PMID: 28818505. DOI: 10.1016/j.schres.2017.08.008
Published
2020/08/28
Issue
Vol. 26 No. 2 (2020): SCIENTIFIC JOURNAL OF EMERGENCY MEDICINE Halo 194
Section
Case report
Autori koji objavljuju u ovom časopisu pristaju na sledeće uslove:

  1. Autori zadržavaju autorska prava i pružaju časopisu pravo prvog objavljivanja rada i licenciraju ga "Creative Commons Attribution licencom" koja omogućava drugima da dele rad, uz uslov navođenja autorstva i izvornog objavljivanja u ovom časopisu.

  2. Autori mogu izraditi zasebne, ugovorne aranžmane za neekskluzivnu distribuciju članka objavljenog u časopisu (npr. postavljanje u institucionalni repozitorijum ili objavljivanje u knjizi), uz navođenje da je članak izvorno objavljen u ovom časopisu.

  3. Autorima je dozvoljeno i podstiču se da postave objavljeni članak onlajn (npr. u institucionalni repozitorijum ili na svoju internet stranicu) pre ili tokom postupka prijave rukopisa, s obzirom da takav postupak može voditi produktivnoj razmeni ideja i ranijoj i većoj citiranosti objavljenog članka (Vidi Efekti otvorenog pristupa).